BDXNYSESurgical & Medical Instruments & ApparatusFiscal year ends September 30

BECTON DICKINSON & CO

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$190.74−1.01 (-0.53%)

Close on Oct 19, 2026

Market cap: $52.48B
P/E (TTM): 57.6
Dividend yield: 2.18%

BECTON DICKINSON & CO income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-09-30	FY 2024 2024-09-30	FY 2023 2023-09-30	FY 2022 2022-09-30	FY 2021 2021-09-30	FY 2020 2020-09-30	FY 2019 2019-09-30	FY 2018 2018-09-30	FY 2017 2017-09-30	FY 2016 2016-09-30	FY 2015 2015-09-30	FY 2014 2014-09-30	FY 2013 2013-09-30	FY 2012 2012-09-30	FY 2011 2011-09-30	FY 2010 2010-09-30	FY 2009 2009-09-30	FY 2008 2008-09-30	FY 2007 2007-09-30
Revenue	21,840	20,178	19,372	18,870	19,131	16,074	17,290	15,983	12,093	12,483	10,282	8,446	8,054	7,708	7,584	7,124	6,987	6,898	6,283
Cost of Revenue	11,915	11,053	11,202	10,393	10,500	9,276	9,002	8,714	6,128	6,492	5,587	4,145	3,883	3,755	3,625	3,428	3,312	3,357	3,033
Gross Profit	9,925	9,125	8,170	8,477	8,631	7,577	8,288	7,269	5,942	5,991	4,695	4,301	4,171	3,953	3,959	3,696	3,675	3,540	3,250
Research & Development	1,265	1,190	1,237	1,256	1,279	1,039	1,062	1,004	770	828	632	550	494	472	470	423	405	–	–
Selling, General & Admin	5,278	4,857	4,719	4,709	4,719	4,185	4,332	4,016	2,909	3,005	2,563	2,145	2,422	1,923	1,824	1,691	1,681	1,670	1,584
Total Costs & Expenses	19,261	17,780	17,261	16,588	16,881	15,161	15,530	14,474	10,571	11,053	9,207	6,840	6,800	6,150	5,918	5,542	5,397	5,409	5,098
Operating Income	2,579	2,397	2,111	2,282	2,250	912	1,760	1,509	1,522	1,430	1,074	1,606	1,254	1,558	1,666	1,582	1,590	1,488	1,185
Interest Expense	613	528	452	398	469	528	639	706	521	388	371	135	138	135	84	51	40	36	46
Interest & Investment Income	38	163	49	16	9.00	7.00	12	65	76	21	15	46	40	50	43	–	–	–	–
Income from Equity Investments	–	–	–	–	–	13	18	8.00	3.00	8.00	9.00	13	5.00	12	3.00	4.85	4.54	4.64	–
Other Non-Operating Income	-123	-28	-46	-117	-99	23	43	305	-101	11	21	5.00	9.00	-1.00	-7.00	0.50	-3.85	-1.48	0.94
Merger & Restructuring Charges	275	387	239	123	44	84	–	–	85	526	271	–	–	–	–	–	–	–	–
Asset Impairment Charges	–	–	–	–	–	–	–	–	–	214	72	–	–	–	9.00	–	–	–	–
Gain (Loss) on Investments	-5.00	5.00	-3.00	-35	57	13	18	–	–	–	–	–	–	–	–	–	–	–	–
Gain (Loss) on Sale of Assets	0	0	268	0	0	0	336	0	0	–	–	–	1.00	–	2.00	18	–	–	–
Pretax Income	1,881	2,005	1,662	1,783	1,692	414	1,176	1,173	976	1,074	739	1,522	1,165	1,472	1,618	1,567	1,579	1,490	1,185
Income Tax Expense	203	300	132	148	88	62	-57	862	-124	97	44	337	236	363	417	452	411	412	344
Income from Continuing Operations	1,678	1,705	1,530	1,635	1,604	352	–	–	–	–	695	1,185	929	1,110	1,201	1,115	1,167	1,078	842
Income from Discontinued Operations	0	0	-46	144	488	522	–	–	–	–	0	0	364	60	70	203	64	49	49
Net Income incl. Noncontrolling Interests	–	–	–	–	–	–	–	–	–	–	–	–	1,293	1,170	1,271	1,318	1,232	1,127	–
Net Income	1,678	1,705	1,484	1,779	2,092	874	1,233	311	1,100	976	695	1,185	1,293	1,170	–	–	1,232	1,127	890
Preferred Dividends	0	0	60	90	90	107	152	152	70	0	0	–	–	–	–	–	–	–	–
Net Income to Common	1,678	1,705	1,424	1,689	2,002	767	1,082	159	1,030	976	695	–	–	–	–	–	–	–	–
EPS (Basic)(per share)	5.83	5.88	4.97	5.93	6.92	2.75	4.01	0.62	4.70	4.59	3.43	6.13	6.63	5.69	5.75	5.62	5.12	4.61	3.63
EPS (Diluted)(per share)	5.82	5.86	4.94	5.88	6.85	2.71	3.94	0.60	4.60	4.49	3.35	5.99	6.49	5.59	5.62	5.49	4.99	4.46	3.49
Shares Outstanding (Basic, Weighted)(shares)	288	290	286	285	289	279	270	258	219	213	203	193	195	205	221	234	240	244	–
Shares Outstanding (Diluted, Weighted)(shares)	289	291	288	287	292	282	275	265	224	218	208	198	199	209	226	240	247	253	–
Dividend per Share(per share)	4.16	3.80	3.64	3.48	3.32	3.16	3.08	3.00	2.92	2.64	2.40	2.18	1.98	–	–	1.48	1.32	1.14	–
EBITDA	5,041	4,683	4,399	4,511	4,480	3,027	4,013	3,487	2,610	2,544	1,965	2,168	1,800	2,069	2,160	2,074	2,054	1,960	1,626

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 46.9%
Operating margin: 10.7%
Net margin: 4.0%
Return on equity, FY2025: 6.5%

Financial strength

Current ratio: 0.87
Debt to equity: 0.69
Debt to assets: 33.1%
Cash to current liabilities: 7.5%

Valuation

P/E ratio: 57.6
Price to sales: 2.26
Price to book: 2.15
Dividend yield: 2.18%